Novo Nordisk announced the availability of Wegovy® (semaglutide 2.4 mg) (MAL24126014AZ) in Malaysia, an adjunct treatment option for adults living with obesity and overweight who present with at least one weight-related comorbidity.
HEY! I Am Charmaine Pua, A Malaysian Lifestyle Blogger.
Day dreamer ♥ Sensitive and compassionate by nature ♥ Live for romance ♥ Love to share
